Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):514–515. doi: 10.1111/j.1476-5381.1992.tb09010.x

MK801 attenuates behavioural adaptation to chronic nicotine administration in rats.

M Shoaib 1, I P Stolerman 1
PMCID: PMC1908456  PMID: 1628139

Abstract

The effect of administering MK801 (0.3 mg kg-1) during chronic nicotine (0.4 mg kg-1) treatment was studied on locomotor activity in rats. Sensitization of the locomotor activity response to nicotine was seen with chronic nicotine treatment. This sensitization was attenuated in rats that had received MK801 30 min before the daily nicotine injections during chronic treatment. These results suggest that the NMDA receptor may be involved in the adaptive processes seen with chronic nicotine administration.

Full text

PDF
514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clarke P. B., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol. 1983 Feb;78(2):329–337. doi: 10.1111/j.1476-5381.1983.tb09398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Criswell H. E., Mueller R. A., Breese G. R. Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist. Brain Res. 1990 Apr 2;512(2):284–290. doi: 10.1016/0006-8993(90)90638-R. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274–5278. doi: 10.1073/pnas.85.14.5274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Karler R., Calder L. D., Chaudhry I. A., Turkanis S. A. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 1989;45(7):599–606. doi: 10.1016/0024-3205(89)90045-3. [DOI] [PubMed] [Google Scholar]
  5. Ksir C., Hakan R. L., Kellar K. J. Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berl) 1987;92(1):25–29. doi: 10.1007/BF00215474. [DOI] [PubMed] [Google Scholar]
  6. Morelli M., Di Chiara G. Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning. Psychopharmacology (Berl) 1990;101(2):287–288. doi: 10.1007/BF02244143. [DOI] [PubMed] [Google Scholar]
  7. Ramoa A. S., Alkondon M., Aracava Y., Irons J., Lunt G. G., Deshpande S. S., Wonnacott S., Aronstam R. S., Albuquerque E. X. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther. 1990 Jul;254(1):71–82. [PubMed] [Google Scholar]
  8. Trujillo K. A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 1991 Jan 4;251(4989):85–87. doi: 10.1126/science.1824728. [DOI] [PubMed] [Google Scholar]
  9. Ward L., Mason S. E., Abraham W. C. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol Biochem Behav. 1990 Apr;35(4):785–790. doi: 10.1016/0091-3057(90)90359-p. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES